Scientists have studied how specialized brain cells called microglia respond to the accumulation of toxic proteins in the brain, a feature typical of Alzheimer's. The three major disease risk factors for Alzheimer's — age, sex and genetics — all affect microglia response, raising the possibility that drugs that modulate this response could be useful for treatment.